Beasley Allen Crow Methvin Portis & Miles Pc
Recent News About Beasley Allen Crow Methvin Portis & Miles Pc View More
-
Lawsuits: Facebook, Instagram intentionally designed to be addictive to teens, cause health, societal problems
More than a dozen lawsuits were filed in Chicago and Rockford federal courts, accusing Meta Platforms, parent company of the popular social media apps, of creating "attractive nuisances" that lead to alleged health problems -
Judge: Settlement talks begun in mass action vs Abbvie, others over Androgel, testosterone drugs
A federal judge has put a hold on any further proceedings in the massive, years-long nationwide legal action against Abbvie and other makers of so-called testosterone replacement therapy drugs, saying he wants to give both sides time to complete a potential settlement drug to permanently end the litigation. -
Judge orders new trial, tosses $140M verdict vs AbbVie over Androgel testosterone drug
A federal judge has knocked down a $140 million verdict against pharmaceutical maker AbbVie, ordering a new trial over a man’s claims AbbVie’s Androgel testosterone replacement therapy drug caused him to suffer a heart attack. -
Drug maker AbbVie wants to slip from $140M verdict, says jury ignored evidence
North Chicago-based drug company AbbVie is urging a federal judge to trash a verdict ordering it to cough up $140 million, because its testosterone therapy drug AndroGel contributed to a man's heart attack, contending it has no liability because AndroGel was approved by the FDA. -
Jury: Abbvie falsely marketed Androgel, owes man who suffered heart attack $140M
Drugmaker Abbvie has suffered another big loss in court, as a Chicago federal jury has ordered the North Chicago-based pharmaceutical company to pay out $140 million to another man who claimed he had suffered a heart attack as a result of taking Abbvie’s testosterone therapy drug, Androgel.